On Sept. 15, 2021, Moderna announced new analysis suggesting that the Moderna COVID-19 vaccine was highly effective against circulating variants of concern, including in a vaccine effectiveness study conducted in partnership with Kaiser Permanente Southern California and in a separate recent publication by the U.S. Centers for Disease Control and Prevention.